Treatment success rate for patients treated for MDR-TB in Chile

Chile: Treatment success rate for patients treated for MDR-TB was 64.0% in 2022. ▲ Rising

Latest (2022)
64.0%
Change on year
up 18.5%
World rank
116th
of 163 countries
All-time high
71.0%
in 2016
All-time low
17.0%
in 2008
Years of data
19
2002–2022

Treatment success rate for patients treated for MDR-TB in Chile, 2002–2022

204060802002201220222002: 502004: 432006: 502007: 362008: 172009: 212010: 422011: 502012: 562013: 212014: 312015: 372016: 712017: 482018: 462019: 502020: 592021: 542022: 64

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for treatment success rate for patients treated for mdr-tb in Chile is 64.0%, measured in 2022.

The figure is up 18.5% on the previous year and up 14.3% over ten years.

Over the whole period, treatment success rate for patients treated for mdr-tb in Chile peaked at 71.0% in 2016 and was at its lowest, 17.0%, in 2008.

Chile ranks 116th of 163 countries on this measure, in the middle of the range.

The long-run direction has been consistently rising across the 19 years of available data.

Treatment success rate for patients treated for MDR-TB in Chile, year by year

Annual values for Treatment success rate for patients treated for MDR-TB (%) in Chile, 2002 to 2022.
Year Value Change
2002 50.0%
2004 43.0% -14.0%
2006 50.0% +16.3%
2007 36.0% -28.0%
2008 17.0% -52.8%
2009 21.0% +23.5%
2010 42.0% +100.0%
2011 50.0% +19.0%
2012 56.0% +12.0%
2013 21.0% -62.5%
2014 31.0% +47.6%
2015 37.0% +19.4%
2016 71.0% +91.9%
2017 48.0% -32.4%
2018 46.0% -4.2%
2019 50.0% +8.7%
2020 59.0% +18.0%
2021 54.0% -8.5%
2022 64.0% +18.5%

Averages by decade

DecadeAverage LowestHighest Years
2000s 36.2% 17.0% 50.0% 6
2010s 45.2% 21.0% 71.0% 10
2020s 59.0% 54.0% 64.0% 3

Countries ranked near Chile

  1. 113 Ecuador 65.0% compare
  2. 113 Mongolia 65.0% compare
  3. 113 Russian Federation 65.0% compare
  4. 116 Gambia 64.0% compare
  5. 118 South Africa 63.0% compare
  6. 118 Finland 63.0% compare

See the full ranking of 175 places →

More health data for Chile

All data for Chile →

Frequently asked questions

What is treatment success rate for patients treated for mdr-tb in Chile?
Treatment success rate for patients treated for mdr-tb in Chile was 64.0% in 2022, according to World Health Organization, Global Health Observatory.
What is the highest treatment success rate for patients treated for mdr-tb recorded in Chile?
The highest recorded value was 71.0% in 2016.
What is the lowest treatment success rate for patients treated for mdr-tb recorded in Chile?
The lowest recorded value was 17.0% in 2008.
How does Chile rank for treatment success rate for patients treated for mdr-tb?
Chile ranks 116th out of 163 countries with data for 2022.
Is treatment success rate for patients treated for mdr-tb rising or falling in Chile?
Over the last ten years it is up 14.3%. The long-run trend across the full record is rising.
Where does this Chile data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Treatment success rate for patients treated for MDR-TB in Chile. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 04 September 2026, from https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/chile/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/chile/">Treatment success rate for patients treated for MDR-TB in Chile</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed